In a recent issue of Cell, Di Liberto et al. (2018) elucidate the mechanisms involved in synaptic stripping during viral infection. Infected neurons orchestrate their own synaptic loss downstream of IFNg signaling, ultimately attracting phagocytic monocytes into the CNS through CCL2 production.
Viral infections lead to a strong activation of the immune system, which responds in an effort to limit the spread of virus in the body. The usual immune mechanisms involve CD8 + cytotoxic lymphocytes (CTLs) interacting with infected cells to bring about their death through perforin and granzyme (Lopez et al., 2013) . In the central nervous system (CNS), viral infections can lead to the eventual development of neurological deficits, including epilepsy, loss of motor coordination, and intellectual decline as a consequence of the cellular death or synaptic stripping induced by the immune response. During the development of the CNS, microglia play an important role in the establishment of neuronal networks via synaptic pruning, removing unnecessary synaptic terminals. However, in pathological conditions, activated microglia can cause over-stripping of synapses, and the subsequent development of neuronal pathology (Kettenmann et al., 2013) . In the context of viral infections, the mechanisms involved in CNS damage remain to be fully elucidated, and perhaps depend on the type of virus and mode of infection. For instance, it was previously shown that viral infection using a neurotropic strain of West Nile virus showed complement factor-dependent synaptic stripping of VGLUT1 + synapses leading to impaired spatial learning and persistence of phagocytic microglia after recovery (Vasek et al., 2016) . However, this mechanism is not necessarily ubiquitous to all CNS viral responses. In a recent issue of Cell, Di Liberto and colleagues describe an alternate mechanism of synaptic stripping in the context of the viral dé jà vu model (Di Liberto et al., 2018) . The viral dé jà vu model involves the neonatal infection of mice with an attenuated strain of lymphocytic chorio-meningitis virus (LCMV), which leads to CNS neuron-restricted viral persistence (Kreutzfeldt et al., 2013) . Subsequent infection with wild-type LCMV in late adolescence promotes a strong CD8 + T cell response against an epitope that is shared between the two LCMV strains, leading to severe disease and resulting in impaired motor coordination and balance (Kreutzfeldt et al., 2013) . In contrast to the West Nile virus model (Vasek et al., 2016) , inhibitory synapses are lost, and synaptic stripping in the dé jà vu model is not dependent on complement factors. Rather, it is mediated by a complex interaction between CD8 + T cells, microglia or macrophages, and neurons themselves, which orchestrate their own damage in the end.
Previously, it was shown that the neuronal expression of the interferon-g (IFNg) receptor is required for the development of viral dé jà vu disease (Kreutzfeldt et al., 2013) . Here, the authors elaborate on the mechanisms involved, describing how synaptic loss leads to the development of pathology in this model. Di Liberto and colleagues show that downstream STAT1 phosphorylation by JAK1/2 in neurons upon IFNg receptor activation is required for synapse pathology (Figure 1 , left panel). Primarily inhibitory pre-and postsynaptic terminals identified by GAD65/67 and gephyrin, respectively, are eliminated rather than excitatory VGLUT1 + terminals. Without neuronal STAT1 or phosphorylated STAT1 (pSTAT1), synaptic loss is abolished (Figure 1, right panel) . In an elegant approach using ''RiboTag'' mice in which ribosomes express an HAtagged ribosomal protein upon Cre-mediated recombination, the authors pulled down mRNA from infected neurons and found that they strongly upregulate the expression of the chemokine genes Ccl2 and Cxcl10 in a STAT1-dependent manner, among other genes. CCL2 is a chemokine known to primarily play a role in the attraction of macrophages. Indeed, in the context of the viral dé jà vu model, the authors could show increased numbers of Iba1 + microglia/macrophages in the CNS. Importantly, these cells displayed a more amoeboid morphology compared with Iba1 + cells of carrier mice, and contained synaptic components in LAMP1 + vesicles. Interestingly, a significant proportion of Iba1 + cells did not express TMEM119, a marker specific for microglia, even during an inflammatory response (Bennett et al., 2016) , indicating that most of these cells were monocytederived, namely attracted to the CNS from the periphery. Blocking neuronal CCL2 production also inhibited synaptic stripping (Figure 1, right panel) , as did the inhibition of phagocyte activation with minocycline or the depletion of CCR2 + circulating monocytes, all without affecting the numbers of infiltrating CD8 + T cells or the viral burden in the CNS. Interestingly, the authors found a similar profile in cases of Rasmussen's encephalitis (RE). Here, they found clustering of CD8 + T cells with pSTAT1 and CCL2 expression. Higher numbers of CD8 + T cell clusters correlated with an increased frequency of epileptic seizures. Furthermore, the authors observed an increased contact between phagocytes and neurons, which correlated with reduced synaptic densities, as seen in the viral dé jà vu model. This raises the interesting possibility that the neurons in RE patients might also respond to CD8 + T cells similarly to what was seen in the mice.
Viral infections have been associated with various neurological and psychiatric disorders, which, often enough, also display synaptic pathology (Perry and O'Connor, 2010) . However, any causality between viral infection and neurological disorder is challenging to establish, in part due to the potential lag time that can occur between the actual infection and the subsequent development of pathology. This has been seen in cases of polio, for instance, in which patients develop neurological symptoms many years later, or in the association of childhood viral infection and increased likelihood of developing schizophrenia in adulthood (Khandaker et al., 2012) . While all these various disorders can be associated with one virus or another, what is more important to establish is the mechanisms in place leading to the neurological damage. Notably, Di Liberto and colleagues found a similar pSTAT1-CCL2 signature not only in RE patients, but also in other cases of encephalitis. Furthermore, as Di Liberto and colleagues also discuss, the gene expression signature associated with IFNg signaling can also be found in other CNS diseases, such as in patients with multiple sclerosis or HIV-associated neurocognitive disorders, among others. This indicates that the mechanisms the authors describe that lead to synaptic stripping might be a more general process occurring across neurological disorders. This opens up interesting possibilities for therapeutic intervention, although a better understanding of timing of events would be necessary so as to avoid unwanted consequences.
To summarize, Di Liberto and colleagues found that IFNg produced by invading CD8 + T cells triggers neurons, which in turn produce CCL2 leading to the invasion of monocytes into the CNS. This is an elegant finding showing how the immune system and the CNS can work in concert to abolish viral infection. While the effect of the immune-neuronal response is too strong here and leads to neuronal damage, in other cases, the synergy between these two systems may have a beneficial effect. For example, Filiano and colleagues demonstrated that IFNg produced by T cells in the meninges may act on neurons to promote normal neuronal connectivity (Filiano et al., 2016) . In the absence of IFNg, mice develop social abnormalities that resemble autism in humans. Thus, recent studies show that triggering of neurons by IFNg has a dramatic effect on the steady-state homeostasis of the CNS. Future studies will undoubtedly strengthen our understanding of how molecules and responses exclusively attributed to the immune system until now can also act on other systems, in particular the nervous system, and demonstrate new ways by which these two systems, in fact, work together.
Figure 1. Neurons Orchestrate Synaptic Loss
Left panel: IFNg binds to the IFNg receptor (IFNGR), leading to phosphorylation of STAT1 by JAK1/2. Neurons produce CCL2, leading to the infiltration of CCR2 + monocytes from the circulation, which then proceed to remove synaptic terminals. Right panel: Stat1-deficient neurons or blockade of JAK1/2 functioning prevents the release of CCL2 and subsequent removal of synapses. Similar effects are seen with CCL2-deficient neurons or depletion of CCR2 + monocytes from circulation.
